Client of a consultant lobbyist
ESTEE LAUDER COMPANIES INC. (THE)
- Meetings this Parliament
- 7
- With MPs
- 0
- Since Nov 2021
- 12
- Active registrations
- 1
Most recent reported meeting: Jan 16, 2026.
Lobbying by ESTEE LAUDER COMPANIES INC. (THE): its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingRegistrations in effect
Consultant In effect since Jun 1, 2026
Consultant Angelo Bakoulas of Bluesky Strategy Group Inc.
Consultant lobbyists
- Angelo Bakoulas
Institutions they may lobby: Canada Border Services Agency (CBSA), Employment and Social Development Canada (ESDC), Environment and Climate Change Canada (ECCC), Finance Canada (FIN), Global Affairs Canada (GAC), Health Canada (HC), House of Commons, Innovation, Science and Economic Development Canada (ISED), Prime Minister's Office (PMO), Privy Council Office (PCO), Public Safety Canada (PS), Royal Canadian Mounted Police (RCMP), Senate of Canada
What they're lobbying on (3)Hide details
- Ensuring alignment with proposed regulations and policies dealing with plastics and all other ingredients used in cosmetics under the Canadian Environmental Protection Act.
- International trade agreements, with a focus on the 2026 CUSMA renegotiation, as they relate to promoting regulatory harmonization across trading partners.
- Policies and regulations on cosmetics, natural health products, and over-the-counter drugs as they relate to regulatory modernization and the development of guidelines relating to the manufacturing, packaging, labelling, advertising, sale, exportation and importation of these products.
Registration 952344-378387-4. Look it up in the official Registry
Reported meetings
Spreadsheet-
Reported by Angelo Bakoulas · Consultant
- Justine Frame · Special Assistant, Health Canada (HC)
Policies and regulations on cosmetics, natural health products, and over-the-counter drugs as they relate to regulatory modernization and the development of guidelines relating to the manufacturing, packaging, labelling, advertising, sale, exportation and importation of these products. Read more
-
Reported by Angelo Bakoulas · Consultant
- Justine Frame · Special Assistant, Health Canada (HC)
Policies and regulations on cosmetics, natural health products, and over-the-counter drugs as they relate to regulatory modernization and the development of guidelines relating to the manufacturing, packaging, labelling, advertising, sale, exportation and importation of these products. Read more
-
Reported by Angelo Bakoulas · Consultant
- Charles Vincent · Senior Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
- Sheryl Groeneweg · Director General, Innovation, Science and Economic Development Canada (ISED)
International trade agreements, with a focus on the 2026 CUSMA renegotiation, as they relate to promoting regulatory harmonization across trading partners. Read more
Policies and regulations on cosmetics, natural health products, and over-the-counter drugs as they relate to regulatory modernization and the development of guidelines relating to the manufacturing, packaging, labelling, advertising, sale, exportation and importation of these products.
-
Reported by Angelo Bakoulas · Consultant
- Lynn McDonald · Director General, Global Affairs Canada (GAC)
International trade agreements, with a focus on the 2026 CUSMA renegotiation, as they relate to promoting regulatory harmonization across trading partners.
-
Reported by Angelo Bakoulas · Consultant
- Niloo Boroun · Director of International Policy, Finance Canada (FIN)
- Mackenzy Metcalfe · Policy Advisor, Finance Canada (FIN)
International trade agreements, with a focus on the 2026 CUSMA renegotiation, as they relate to promoting regulatory harmonization across trading partners.
-
Reported by Angelo Bakoulas · Consultant
- Simran Arulraj · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
- Lisa Xie · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
International trade agreements, with a focus on the 2026 CUSMA renegotiation, as they relate to promoting regulatory harmonization across trading partners. Read more
Policies and regulations on cosmetics, natural health products, and over-the-counter drugs as they relate to regulatory modernization and the development of guidelines relating to the manufacturing, packaging, labelling, advertising, sale, exportation and importation of these products.
-
Reported by Angelo Bakoulas · Consultant
- Brandan Rowe · Chief of Staff, Privy Council Office (PCO)
- Galen Richardson · Senior Advisor, Stakeholder Relations, Privy Council Office (PCO)
Policies and regulations on cosmetics, natural health products, and over-the-counter drugs as they relate to regulatory modernization and the development of guidelines relating to the manufacturing, packaging, labelling, advertising, sale, exportation and importation of these products. Read more
International trade agreements, with a focus on the 2026 CUSMA renegotiation, as they relate to promoting regulatory harmonization across trading partners.
-
Reported by Angelo Bakoulas · Consultant
- Jonathan Alomoto · Senior Policy Advisor, Global Affairs Canada (GAC)
International trade agreements, with a focus on the 2026 CUSMA renegotiation, as they relate to promoting regulatory harmonization across trading partners.
-
Reported by Angelo Bakoulas · Consultant
- Shaun Chen · Member of Parliament, House of Commons
International trade agreements, with a focus on the 2026 CUSMA renegotiation, as they relate to promoting regulatory harmonization across trading partners.
-
Reported by Angelo Bakoulas · Consultant
- Laurel Chester · Senior Advisor, Innovation, Science and Economic Development Canada (ISED)
- Simran Arulraj · Advisor, Ontario and Atlantic, Innovation, Science and Economic Development Canada (ISED)
- Lisa Xie · Advisor, West and North, Innovation, Science and Economic Development Canada (ISED)
Policies and regulations on cosmetics, natural health products, and over-the-counter drugs as they relate to regulatory modernization and the development of guidelines relating to the manufacturing, packaging, labelling, advertising, sale, exportation and importation of these products. Read more
International trade agreements, with a focus on the 2026 CUSMA renegotiation, as they relate to promoting regulatory harmonization across trading partners.
-
Reported by Angelo Bakoulas · Consultant
- Zachary Nixon · Ontario Regional Advisor, Prime Minister's Office (PMO)
International trade agreements, with a focus on the 2026 CUSMA renegotiation, as they relate to promoting regulatory harmonization across trading partners.
-
Reported by Angelo Bakoulas · Consultant
- Victoria Dempster · Senior Advisor, Employment and Social Development Canada (ESDC)
- Andreea Campobasso · Director of Issues Management, Employment and Social Development Canada (ESDC)
International trade agreements, with a focus on the 2026 CUSMA renegotiation, as they relate to promoting regulatory harmonization across trading partners.
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.